PDBZX | PTTCX | PDBZX / PTTCX | |
Total Expense Ratio | 0.49 | 1.62 | 30% |
Annual Report Gross Expense Ratio | 0.50 | 1.62 | 31% |
Fund Existence | 29 years | 29 years | - |
Gain YTD | 6.373 | 6.226 | 102% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 1000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 51.2B | 44.8B | 114% |
Annual Yield % from dividends | 4.60 | 3.47 | 132% |
Returns for 1 year | 3.83 | 3.11 | 123% |
Returns for 3 years | 14.37 | 10.75 | 134% |
Returns for 5 years | -0.05 | -8.16 | 1% |
Returns for 10 years | 23.53 | 5.46 | 431% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
IVLU | 35.43 | 0.37 | +1.06% |
iShares Edge MSCI Intl Value Factor ETF | |||
NUMG | 49.19 | 0.39 | +0.80% |
Nuveen ESG Mid-Cap Growth ETF | |||
EJAN | 32.95 | 0.14 | +0.41% |
Innovator Emerging Mkt Pwr Buff ETF™ Jan | |||
BOXA | 105.00 | 0.26 | +0.25% |
Alpha Architect Aggregate Bond ETF | |||
FTXH | 28.19 | -0.07 | -0.26% |
First Trust Nasdaq Pharmaceuticals ETF |